Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019
Joann F. Kekeisen-Chen
, Felix T. Tarbangdo, Shalabh Sharma, Daya Marasini, Henju Marjuki, Janelle L. Kibler, Heather E. Reese, Seydou Ouattara, Flavien H. Ake, Issaka Yameogo, Issa Ouedraogo, Emmanuel Seini, Robert L. Zoma, Issa Tonde, Mahamoudou Sanou, Ryan T. Novak
1, and Lucy A. McNamara
1
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.F. Kekeisen-Chen, S. Sharma, D. Marasini, H. Marjuki, J.L. Kibler, H.E. Reese, R.T. Novak, L.A. McNamara); Davycas International, Ouagadougou, Burkina Faso (F.T. Tarbangdo, F.H. Ake, R.L. Zoma); Ministère de la Santé, Ouagadougou (S. Ouattara, I. Yameogo, I. Ouedraogo, E. Seini); Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouagadougou (I. Tonde, M. Sanou); Université Joseph Ki-Zerbo, Ouagadougou (I. Tonde, M. Sanou)
Main Article
Figure 2
Figure 2. Meningitis cumulative incidence (cases/100,000 population) across 6 affected districts in the Sahel and Est regions of Burkina Faso in study of expansion of Neisseria meningitidis serogroup C clonal complex 10217 during meningitis outbreak, January 28–May 5, 2019. Colors indicate incidence of meningitis cases per 100,000 population. Inset map shows location of surveilled regions in Burkina Faso.
Main Article
Page created: December 31, 2023
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.